Primary injection sites for AOD-9604 include the abdominal area (around the navel, varying position each injection), the front of the thighs (alternating legs), and the back of the upper arms (alternating arms)
What puts you at risk
Seek urgent medical attention (via NHS 111 or 999 in an emergency) if you experience severe or persistent abdominal pain, persistent vomiting, signs of dehydration (such as dizziness, reduced urination, or extreme thirst), or symptoms suggestive of low blood sugar (such as shakiness, sweating, or confusion)
Cant wait to see results Love love love this place
doi: 10.1002/dta.1715
Related studies mainly focus on in vivo intervention efficacy validation, exploration of combined intervention strategies, and optimization of pharmaceutical dosage forms, providing important experimental evidence for clinical intervention of obesity